1. JCO Precis Oncol. 2021 Apr 22;5:PO.20.00278. doi: 10.1200/PO.20.00278. 
eCollection 2021.

Response to Cabozantinib Following Acquired Entrectinib Resistance in a Patient 
With ETV6-NTRK3 Fusion-Positive Carcinoma Harboring the NTRK3 (G623R) 
Solvent-Front Mutation.

Hanf D(1)(2)(3), Heining C(1)(2)(3), Laaber K(4)(5), Nebelung H(6), Uhrig 
S(7)(8)(9), Hutter B(7)(8)(9), Jahn A(1)(2)(3)(10)(11)(12), Richter D(1)(2)(3), 
Aust D(13), Herbst F(4), Fröhling S(9)(14), Glimm H(1)(2)(3)(4), Folprecht 
G(12)(15).

Author information:
(1)Department of Translational Medical Oncology, National Center for Tumor 
Diseases (NCT) and DKFZ Dresden, Dresden, Germany.
(2)Center for Personalized Oncology, National Center for Tumor Diseases (NCT) 
Dresden and University Hospital Carl Gustav Carus Dresden at TU Dresden, 
Dresden, Germany.
(3)German Cancer Consortium (DKTK), Dresden, Germany.
(4)Translational Functional Cancer Genomics, National Center for Tumor Diseases 
(NCT) and German Cancer Research Center (DKFZ), Heidelberg, Germany.
(5)Faculty of Biosciences, Heidelberg University, Heidelberg, Germany.
(6)Department of Radiology, University Hospital Carl Gustav Carus Dresden, 
Dresden, Germany.
(7)Division of Applied Bioinformatics, German Cancer Research Center (DKFZ), 
Heidelberg, Germany.
(8)Computational Oncology, Molecular Diagnostics Program, National Center for 
Tumor Diseases, DKFZ, Heidelberg, Germany.
(9)German Cancer Consortium (DKTK), Heidelberg, Germany.
(10)Institute for Clinical Genetics, Faculty of Medicine Carl Gustav Carus, 
Technische Universität Dresden, Dresden, Germany.
(11)ERN-GENTURIS, Hereditary Cancer Syndrome Center Dresden, Dresden, Germany.
(12)National Center for Tumor Diseases (NCT), Partner Site Dresden, Germany and 
German Cancer Research Center (DKFZ), Heidelberg, Germany.
(13)Institute of Pathology, University Hospital Carl Gustav Carus Dresden, 
Dresden, Germany.
(14)Department of Translational Medical Oncology, National Center for Tumor 
Diseases (NCT) Heidelberg and German Cancer Research Center (DKFZ), Heidelberg, 
Germany.
(15)Medical Department/University Cancer Center, University Hospital Carl Gustav 
Carus Dresden, Dresden, Germany.

DOI: 10.1200/PO.20.00278
PMCID: PMC8232550
PMID: 34250401 [Indexed for MEDLINE]